We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection

By LabMedica International staff writers
Posted on 11 Dec 2024

Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low concentrations—such as those found in the early stages of diseases—has been challenging. Now, a new breakthrough in nanotechnology for biomolecule detection and analysis could open doors to more effective early disease detection methods.

In a study conducted at SMU Lyle (Dallas, TX, USA) and featured on the cover of Analytical Chemistry, researchers combined octahedral DNA origami structures with solid-state nanopores to enhance the detection of proteins, particularly those present in low concentrations. The researchers found that integrating DNA origami's precision with the strength of solid-state nanopores results in a "hybrid nanopore" system, offering more accurate and sensitive protein detection. DNA origami is a technique in which DNA strands are folded into specific shapes, such as an octahedron, to improve the nanopore’s capacity to capture and detect proteins. In their study, the researchers used holo human serum transferrin as a model protein, demonstrating that this hybrid nanopore system outperformed traditional nanopores in both sensitivity and detection accuracy.

Many diseases, including cancer and neurodegenerative disorders, are marked by proteins present in very small quantities, making them difficult to detect in the early stages. The hybrid nanopore's ability to detect these low-abundance proteins could lead to earlier diagnoses and more effective treatment outcomes. Moving forward, the research team plans to refine the DNA origami structure and nanopore configurations to further improve sensitivity and expand the range of detectable biomolecules. This innovative approach could revolutionize fields like drug discovery, disease diagnostics, and fundamental biological research.

“This work could pave the way for developing advanced biosensing technologies, with potential applications in biomedical research and diagnostic tools – especially for diseases marked by low-abundance protein biomarkers,” said SMU Lyle mechanical engineering graduate student Kamruzzaman Joty.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
TORCH Infections Test
TORCH Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.